The PharmTech Group spoke with BIOVECTRA's director of Business Development, Nucleic Acid Modalities, Jessica Madigan, about the concept of flexibility in outsourcing and the 2024 BIO Convention.
The Centers for Medicare and Medicaid Services is redesigning its innovation center to give providers greater flexibility in payment models while encouraging greater competition among healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback